Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study—A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline
Standard
Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study—A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline. / Röhr, Susanne; Zülke, Andrea; Luppa, Melanie; Brettschneider, Christian; Weißenborn, Marina; Kühne, Flora; Zöllinger, Isabel; Samos, Franziska-Antonia Zora; Bauer, Alexander; Döhring, Juliane; Krebs-Hein, Kerstin; Oey, Anke; Czock, David; Frese, Thomas; Gensichen, Jochen; Haefeli, Walter E.; Hoffmann, Wolfgang; Kaduszkiewicz, Hanna; König, Hans-Helmut; Thyrian, Jochen René; Wiese, Birgitt; Riedel-Heller, Steffi G.
in: INT J ENV RES PUB HE, Jahrgang 18, Nr. 2, 07.01.2021, S. 408.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Recruitment and Baseline Characteristics of Participants in the AgeWell.de Study—A Pragmatic Cluster-Randomized Controlled Lifestyle Trial against Cognitive Decline
AU - Röhr, Susanne
AU - Zülke, Andrea
AU - Luppa, Melanie
AU - Brettschneider, Christian
AU - Weißenborn, Marina
AU - Kühne, Flora
AU - Zöllinger, Isabel
AU - Samos, Franziska-Antonia Zora
AU - Bauer, Alexander
AU - Döhring, Juliane
AU - Krebs-Hein, Kerstin
AU - Oey, Anke
AU - Czock, David
AU - Frese, Thomas
AU - Gensichen, Jochen
AU - Haefeli, Walter E.
AU - Hoffmann, Wolfgang
AU - Kaduszkiewicz, Hanna
AU - König, Hans-Helmut
AU - Thyrian, Jochen René
AU - Wiese, Birgitt
AU - Riedel-Heller, Steffi G.
PY - 2021/1/7
Y1 - 2021/1/7
N2 - Targeting dementia prevention, first trials addressing multiple modifiable risk factors showed promising results in at-risk populations. In Germany, AgeWell.de is the first large-scale initiative investigating the effectiveness of a multi-component lifestyle intervention against cognitive decline. We aimed to investigate the recruitment process and baseline characteristics of the AgeWell.de participants to gain an understanding of the at-risk population and who engages in the intervention. General practitioners across five study sites recruited participants (aged 60-77 years, Cardiovascular Risk Factors, Aging, and Incidence of Dementia/CAIDE dementia risk score ≥ 9). Structured face-to-face interviews were conducted with eligible participants, including neuropsychological assessments. We analyzed group differences between (1) eligible vs. non-eligible participants, (2) participants vs. non-participants, and (3) between intervention groups. Of 1176 eligible participants, 146 (12.5%) dropped out before baseline; the study population was thus 1030 individuals. Non-participants did not differ from participants in key sociodemographic factors and dementia risk. Study participants were M = 69.0 (SD = 4.9) years old, and 52.1% were women. The average Montreal Cognitive Assessment/MoCA score was 24.5 (SD = 3.1), indicating a rather mildly cognitively impaired study population; however, 39.4% scored ≥ 26, thus being cognitively unimpaired. The bandwidth of cognitive states bears the interesting potential for differential trial outcome analyses. However, trial conduction is impacted by the COVID-19 pandemic, requiring adjustments to the study protocol with yet unclear methodological consequences.
AB - Targeting dementia prevention, first trials addressing multiple modifiable risk factors showed promising results in at-risk populations. In Germany, AgeWell.de is the first large-scale initiative investigating the effectiveness of a multi-component lifestyle intervention against cognitive decline. We aimed to investigate the recruitment process and baseline characteristics of the AgeWell.de participants to gain an understanding of the at-risk population and who engages in the intervention. General practitioners across five study sites recruited participants (aged 60-77 years, Cardiovascular Risk Factors, Aging, and Incidence of Dementia/CAIDE dementia risk score ≥ 9). Structured face-to-face interviews were conducted with eligible participants, including neuropsychological assessments. We analyzed group differences between (1) eligible vs. non-eligible participants, (2) participants vs. non-participants, and (3) between intervention groups. Of 1176 eligible participants, 146 (12.5%) dropped out before baseline; the study population was thus 1030 individuals. Non-participants did not differ from participants in key sociodemographic factors and dementia risk. Study participants were M = 69.0 (SD = 4.9) years old, and 52.1% were women. The average Montreal Cognitive Assessment/MoCA score was 24.5 (SD = 3.1), indicating a rather mildly cognitively impaired study population; however, 39.4% scored ≥ 26, thus being cognitively unimpaired. The bandwidth of cognitive states bears the interesting potential for differential trial outcome analyses. However, trial conduction is impacted by the COVID-19 pandemic, requiring adjustments to the study protocol with yet unclear methodological consequences.
U2 - 10.3390/ijerph18020408
DO - 10.3390/ijerph18020408
M3 - SCORING: Journal article
VL - 18
SP - 408
JO - INT J ENV RES PUB HE
JF - INT J ENV RES PUB HE
SN - 1660-4601
IS - 2
ER -